Lamivudine
- Product NDC
- 54838-566
- 11-digit product format
- 548380566
- Labeler code
- 54838
- Product ID
- 54838-566_b73db9be-cc57-417b-8545-43fbc355978d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamivudine
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Lannett Company, Inc.
- Application
- ANDA203564
- Marketing category
- ANDA
- Marketing start
- 2014-10-31
- Marketing end
- 0000-00-00
- Substance
- LAMIVUDINE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 54838-566-70 | 54838056670 | 240 mL in 1 BOTTLE, PLASTIC (54838-566-70) | 240 ml | 2014-10-31 | 0000-00-00 | No | No | Current |